These developments of 2025 point to the recognition of GLP-1 as a product design vertical across food, supplement, and wellness platforms
Laboratory Applications of GHK-CU Nasal Format In research settings, GHK-CU nasal formulation is utilized primarily in analytical studies, receptor binding assays, and experimental modeling of peptide delivery systems
Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury
Metabolic markers HbA1c, lipids, kidney markers, and liver enzymes give useful context when GLP-1 therapy and supplements affect appetite, hydration, or blood sugar
One animal in the single MEDI7219 10 mg dose group for the glucose tolerance test was excluded from analysis due to a likely error in dosing